Researchers have demonstrated a novel two-step strategy to label and eradicate cancer stem-like cells (CSC) to improve cancer treatment prognosis.

Scientists often build new protein molecules by stringing groups of amino acids together. These amino acid chains, called polypeptides, are the building blocks needed in drug development and the creation of new biomaterials.